This Billion Operational Beat Reshapes AbbVie Thesis for Investors
AbbVie blew past first-quarter expectations with a $15.002 billion revenue print and raised full-year guidance, under...
Knowing when to rebalance keeps your retirement plan on track. This intro covers indicators and a simple action plan.
17,694 articlesAbbVie blew past first-quarter expectations with a $15.002 billion revenue print and raised full-year guidance, under...
SpaceX’s public-market debut fueled an ascent in Elon Musk’s net worth to about $1.32 trillion, surpassing Bitcoin’s ...
A major U.S. player in rare-earth magnets has fallen from its peak as policy shifts promise supply-chain resilience. ...
SQQQ has endured sustained daily reset losses that compound over time, erasing most of its value even as the Nasdaq-1...
Investors are pouring money into XRP-, SOL-, and HYPE-linked ETFs even as BTC and ETH trackers fall behind. The lates...
David Tepper accelerates a $400 million macro bet pairing a country ETF with a memory-chip giant, underscoring what s...
Insider moves can reveal how company insiders view the path ahead. This guide breaks down what it means when a chief ...
Investors are watching Micron ahead of earnings day. This guide breaks down three essential signals that could push M...
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Bank of America says Micron Technology is trading at a sub-10x forward multiple despite a structural shift toward AI-...
A veteran SpaceX backer contends the $2 trillion IPO valuation understates the long-term growth in space infrastructu...
As AI fuels data growth, Silicon Motion Technology stands out in the memory controller niche. This article breaks dow...